Home

Commodore Capital reported a 4.9% stake in Nurix Therapeutics NRIX · 3,780,055 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
4.9%
Last report
5.1% · filed 25/02/14
Shares held
3,780,055 sh
Class
Common Stock, par value $0.001 per share
Event date
25/09/30
Filed
25/11/14

4.9% stake · below 5%

Stake
4.9%
Last report
5.1%
Since last report
−0.2pp

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Commodore Capital's other 5% stake reports

  • Commodore Capital

    5% stakeJatt III Acquisition

    5.2% stake

    Filed 09/02

  • Commodore Capital

    5% stakeInflaRx

    5.1% stake

    Filed 08/17

  • Commodore Capital

    5% stakePalisade Bio

    0% stake

    Filed 08/14

  • Commodore Capital

    5% stakeJatt II Acquisition

    0% stake

    Filed 08/14

  • Commodore Capital

    5% stakeRelay Therapeutics

    5.5% stake

    Filed 08/14